Pressure BioSciences to acquire the assets of a global, eco-friendly agrochemical supplier for worldwide distribution into food production markets Assets include formulations, manufacturer relationships, trademarks and other IP, registrations, licenses, and access to distributors and end-users Assets are being acquired from a company that was selling improved, effective, organically-natural, “green” agrochemical products Company expects that … Continue reading “Pressure BioSciences, Inc. (PBIO) Announces Plans to Acquire the Assets of Global Eco-Friendly Agrochemical Supplier”
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced its entry into a letter of intent to purchase the assets of an internationally based developer and supplier of organically natural, eco-friendly agrochemicals. … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) to Acquire Assets of International Agrochemical Developer and Supplier”
Pressure BioSciences (OTCQB: PBIO), today announced a collaboration with SinuSys Corporation aimed at evauating the potential for PBI’s innovative Ultra Shear Technology(TM) (“UST”) platform to strengthen the effectiveness of SinuSys Corp’s lead product candidate Restora. Depending on the outcome of the collaboration, SinuSys plans to license PBI’s UST platform for use with Restora on its path … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Collaboration to Evaluate Feasibility of Ultra Shear Technology Platform to Improve Effectiveness of SinuSys Lead Product Candidate”
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced a remarkable convergence of global research teams declaring pivotal new insights into COVID-19 biology and disease processes. According to the update, all teams selected PBI’s Pressure Cycling … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Selected as ‘Method of Choice’ for Many Global Research Teams”
Pressure BioSciences (OTCQB: PBIO) has announced that it will be presenting at the upcoming Life Sciences Investor Forum (“LSIF”). The leading proprietary investor conference is scheduled for Dec. 17, 2020, and is a live, interactive investor event held quarterly for public and private companies, investors and industry professionals from around the world. The daylong event features … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Slated to Present at Leading Investor Forum”
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently reported its third-quarter financial results and provided a business update, which included initial expectations for 2021 (https://nnw.fm/h9g1G). Among the updates, the Q3 2020 Form 10-Q financial report outlines measurable progress in three important areas: key operational … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) on Track to Launch BaroShear K45 Nanoemulsification System in 2021”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced that its proposed acquisition partner Cannaworx Inc. has set December 2020 as the commercial launch date for its patented immune booster supplement: ImmunaZin(TM). According to the update, Cannaworx … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Commercial Launch Date for ImmunaZin(TM)”
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently secured its first U.S. patent for its innovative Ultra Shear Technology (“UST”) platform. Utilizing ultra-high pressure and intense shearing forces, the platform creates unique, high-quality nanoemulsions that have enormous use in a wide variety of industries. … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Looks to Provide Key to Commercial Success of Novel Products”
Measurable success achieved in Q3 2020 in key financial, operational, and technical projects Revenue increases reported in products and services offerings; balance sheet improved with significant reduction in variable-rate debt Q3 total revenue exceeded Q1 and Q2 total revenue combined Company reported receipt of 12 pre-orders for the innovative BaroShear K45, which is on track … Continue reading “Pressure BioSciences, Inc. (PBIO) Reports Revenue Hike in Q3, While Achieving Its Best Financial Quarter in Two Years; Company Expects Strong 2021”
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, on Tuesday released financial results for the third quarter ended September 30, 2020. In addition, the company provided a business update and offered limited guidance for fiscal year … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q3 2020 Financial Results, Provides Business Update”
